Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 371

1.

The association between HIV infection and mitochondrial DNA copy number in peripheral blood: a population-based, prospective cohort study.

Sun J, Longchamps RJ, Piggott DA, Castellani CA, Sumpter JA, Brown TT, Mehta SH, Arking DE, Kirk GD.

J Infect Dis. 2018 Nov 24. doi: 10.1093/infdis/jiy658. [Epub ahead of print]

PMID:
30476184
2.

Health insurance coverage is associated with access to substance use treatment among individuals with injection drug use: Evidence from a 12-year prospective study.

Feder KA, Krawczyk N, Mojtabai R, Crum RM, Kirk G, Mehta SH.

J Subst Abuse Treat. 2019 Jan;96:75-81. doi: 10.1016/j.jsat.2018.08.012. Epub 2018 Aug 28.

PMID:
30466552
3.

Reduced Forced Vital Capacity among HIV-infected middle-aged individuals.

Verboeket SO, Wit FW, Kirk GD, Drummond MB, van Steenwijk RP, van Zoest RA, Nellen JF, van der Loeff MFS, Reiss P; AGEh IV study group.

J Infect Dis. 2018 Nov 12. doi: 10.1093/infdis/jiy653. [Epub ahead of print]

PMID:
30418599
4.

Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1.

Boelen L, Debebe B, Silveira M, Salam A, Makinde J, Roberts CH, Wang ECY, Frater J, Gilmour J, Twigger K, Ladell K, Miners KL, Jayaraman J, Traherne JA, Price DA, Qi Y, Martin MP, Macallan DC, Thio CL, Astemborski J, Kirk G, Donfield SM, Buchbinder S, Khakoo SI, Goedert JJ, Trowsdale J, Carrington M, Kollnberger S, Asquith B.

Sci Immunol. 2018 Nov 9;3(29). pii: eaao2892. doi: 10.1126/sciimmunol.aao2892.

PMID:
30413420
5.

Military-Civilian Partnerships in Training, Sustaining, Recruitment, Retention, and Readiness: Proceedings from an Exploratory First-Steps Meeting.

Knudson MM, Elster EA, Bailey JA, Johannigman JA, Bailey PV, Schwab CW, Kirk GG, Woodson JA.

J Am Coll Surg. 2018 Aug;227(2):284-292. doi: 10.1016/j.jamcollsurg.2018.04.030. Epub 2018 May 23. No abstract available.

PMID:
29802978
6.

Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy.

Chettimada S, Lorenz DR, Misra V, Dillon ST, Reeves RK, Manickam C, Morgello S, Kirk GD, Mehta SH, Gabuzda D.

Sci Rep. 2018 May 8;8(1):7227. doi: 10.1038/s41598-018-25515-4.

7.

The Role of Mitochondrial DNA Variation in Age-Related Decline in Gait Speed Among Older Men Living With Human Immunodeficiency Virus.

Sun J, Brown TT, Samuels DC, Hulgan T, D'Souza G, Jamieson BD, Erlandson KM, Martinson J, Palella FJ Jr, Margolick JB, Kirk GD, Schrack JA.

Clin Infect Dis. 2018 Aug 16;67(5):778-784. doi: 10.1093/cid/ciy151.

PMID:
29481608
8.

A Model of Uranium Uptake by Plant Roots Allowing for Root-Induced Changes in the soil.

Boghi A, Roose T, Kirk GJD.

Environ Sci Technol. 2018 Mar 20;52(6):3536-3545. doi: 10.1021/acs.est.7b06136. Epub 2018 Mar 2.

PMID:
29466669
9.

Prescription drug use and misuse in a cohort of people who inject drugs (PWID) in Baltimore.

Anagnostopoulos A, Abraham AG, Genberg BL, Kirk GD, Mehta SH.

Addict Behav. 2018 Jun;81:39-45. doi: 10.1016/j.addbeh.2018.01.024. Epub 2018 Feb 2.

PMID:
29425791
10.

Avoidance, meaning and grief: psychosocial factors influencing engagement in HIV care.

Michlig GJ, Westergaard RP, Lam Y, Ahmadi A, Kirk GD, Genz A, Keruly J, Hutton H, Surkan PJ.

AIDS Care. 2018 Apr;30(4):511-517. doi: 10.1080/09540121.2018.1425366. Epub 2018 Jan 17.

PMID:
29338328
11.

Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells.

Ramsuran V, Naranbhai V, Horowitz A, Qi Y, Martin MP, Yuki Y, Gao X, Walker-Sperling V, Del Prete GQ, Schneider DK, Lifson JD, Fellay J, Deeks SG, Martin JN, Goedert JJ, Wolinsky SM, Michael NL, Kirk GD, Buchbinder S, Haas D, Ndung'u T, Goulder P, Parham P, Walker BD, Carlson JM, Carrington M.

Science. 2018 Jan 5;359(6371):86-90. doi: 10.1126/science.aam8825. Epub 2018 Jan 4.

12.

HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D.

Shiels MS, Kirk GD, Drummond MB, Dhillon D, Hanash SM, Taguchi A, Engels EA.

J Infect Dis. 2018 Jan 17;217(3):413-417. doi: 10.1093/infdis/jix510.

PMID:
29272472
13.

Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, Uganda.

Boon D, Redd AD, Laeyendecker O, Engle RE, Nguyen H, Ocama P, Boaz I, Ndyanabo A, Kiggundu V, Reynolds SJ, Gray RH, Wawer MJ, Purcell RH, Kirk GD, Quinn TC, Stabinski L; Rakai Health Sciences Program.

J Infect Dis. 2018 Feb 14;217(5):785-789. doi: 10.1093/infdis/jix610.

PMID:
29186448
14.

Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection.

Adland E, Hill M, Lavandier N, Csala A, Edwards A, Chen F, Radkowski M, Kowalska JD, Paraskevis D, Hatzakis A, Valenzuela-Ponce H, Pfafferott K, Williams I, Pellegrino P, Borrow P, Mori M, Rockstroh J, Prado JG, Mothe B, Dalmau J, Martinez-Picado J, Tudor-Williams G, Frater J, Stryhn A, Buus S, Teran GR, Mallal S, John M, Buchbinder S, Kirk G, Martin J, Michael N, Fellay J, Deeks S, Walker B, Avila-Rios S, Cole D, Brander C, Carrington M, Goulder P.

J Virol. 2018 Jan 30;92(4). pii: e01685-17. doi: 10.1128/JVI.01685-17. Print 2018 Feb 15.

15.

Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection.

Huang H, Duggal P, Thio CL, Latanich R, Goedert JJ, Mangia A, Cox AL, Kirk GD, Mehta S, Aneja J, Alric L, Donfield SM, Cramp ME, Khakoo SI, Tobler LH, Busch M, Alexander GJ, Rosen HR, Edlin BR, Segal FP, Lauer GM, Thomas DL, Daly MJ, Chung RT, Kim AY.

Sci Rep. 2017 Nov 20;7(1):15843. doi: 10.1038/s41598-017-16011-2.

16.

Differential Relationships among Circulating Inflammatory and Immune Activation Biomediators and Impact of Aging and Human Immunodeficiency Virus Infection in a Cohort of Injection Drug Users.

Kirk GD, Dandorf S, Li H, Chen Y, Mehta SH, Piggott DA, Margolick JB, Leng SX.

Front Immunol. 2017 Oct 19;8:1343. doi: 10.3389/fimmu.2017.01343. eCollection 2017.

17.

Soil CO2 venting as one of the mechanisms for tolerance of Zn deficiency by rice in flooded soils.

Affholder MC, Weiss DJ, Wissuwa M, Johnson-Beebout SE, Kirk GJD.

Plant Cell Environ. 2017 Dec;40(12):3018-3030. doi: 10.1111/pce.13069. Epub 2017 Nov 10.

18.

Postmortem Organ Weights at a South African Mortuary.

Peddle L, Kirk GM.

Am J Forensic Med Pathol. 2017 Dec;38(4):277-282. doi: 10.1097/PAF.0000000000000340.

PMID:
28825945
19.

Long-term increases in soil carbon due to ecosystem fertilization by atmospheric nitrogen deposition demonstrated by regional-scale modelling and observations.

Tipping E, Davies JAC, Henrys PA, Kirk GJD, Lilly A, Dragosits U, Carnell EJ, Dore AJ, Sutton MA, Tomlinson SJ.

Sci Rep. 2017 May 15;7(1):1890. doi: 10.1038/s41598-017-02002-w.

20.

HIV/HCV Co-infection, Liver Disease Progression, and Age-Related IGF-1 Decline.

Quinn J, Astemborski J, Mehta SH, Kirk GD, Thomas DL, Balagopal A.

Pathog Immun. 2017;2(1):50-59. doi: 10.20411/pai.v2i1.183. Epub 2017 Mar 3.

21.

Anomalous biliary and vascular anatomy-Potential pitfalls during cholecystectomy.

Grimes N, Mark D, McKie L, Scoffield J, Kirk G, Taylor M, Diamond T.

Clin Anat. 2017 Nov;30(8):1103-1106. doi: 10.1002/ca.22895. Epub 2017 May 22.

PMID:
28470709
22.

Seasonality and breeding success of captive and wild Tasmanian devils (Sarcophilus harrisii).

Keeley T, Russell T, Carmody K, Kirk G, Eastley T, Britt-Lewis A, Post M, Burridge M, Eccleston S, Faulkner T, Forge T, Leonard J, Hughes RL.

Theriogenology. 2017 Jun;95:33-41. doi: 10.1016/j.theriogenology.2017.02.013. Epub 2017 Feb 24.

PMID:
28460677
23.

Acceptability of a mobile health intervention to enhance HIV care coordination for patients with substance use disorders.

Westergaard RP, Genz A, Panico K, Surkan PJ, Keruly J, Hutton HE, Chang LW, Kirk GD.

Addict Sci Clin Pract. 2017 Apr 26;12(1):11. doi: 10.1186/s13722-017-0076-y.

24.

Increased Mortality Among Persons With Chronic Hepatitis C With Moderate or Severe Liver Disease: A Cohort Study.

Cepeda JA, Thomas DL, Astemborski J, Sulkowski MS, Kirk GD, Mehta SH.

Clin Infect Dis. 2017 Jul 15;65(2):235-243. doi: 10.1093/cid/cix207.

25.

Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections.

Vergara C, Thio C, Latanich R, Cox AL, Kirk GD, Mehta SH, Busch M, Murphy EL, Villacres MC, Peters MG, French AL, Golub E, Eron J, Lahiri CD, Shrestha S, Gustafson D, Young M, Anastos K, Aouizerat B, Kim AY, Lauer G, Thomas DL, Duggal P.

Genes Immun. 2017 Mar;18(2):82-87. doi: 10.1038/gene.2017.2. Epub 2017 Mar 16.

26.

Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis.

Pavasini R, Guralnik J, Brown JC, di Bari M, Cesari M, Landi F, Vaes B, Legrand D, Verghese J, Wang C, Stenholm S, Ferrucci L, Lai JC, Bartes AA, Espaulella J, Ferrer M, Lim JY, Ensrud KE, Cawthon P, Turusheva A, Frolova E, Rolland Y, Lauwers V, Corsonello A, Kirk GD, Ferrari R, Volpato S, Campo G.

BMC Med. 2016 Dec 22;14(1):215. doi: 10.1186/s12916-016-0763-7. Review.

27.

HIV Infection Is Independently Associated with Increased CT Scan Lung Density.

Drummond MB, Lambert AA, Hussien AF, Lin CT, Merlo CA, Wise RA, Kirk GD, Brown RH.

Acad Radiol. 2017 Feb;24(2):137-145. doi: 10.1016/j.acra.2016.09.019. Epub 2016 Nov 18.

28.

HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease.

Popescu I, Drummond MB, Gama L, Lambert A, Hoji A, Coon T, Merlo CA, Wise RA, Keruly J, Clements JE, Kirk GD, McDyer JF.

J Infect Dis. 2016 Nov 15;214(10):1520-1530. Epub 2016 Sep 9.

29.

Experimental Determination of Zinc Isotope Fractionation in Complexes with the Phytosiderophore 2'-Deoxymugeneic Acid (DMA) and Its Structural Analogues, and Implications for Plant Uptake Mechanisms.

Marković T, Manzoor S, Humphreys-Williams E, Kirk GJ, Vilar R, Weiss DJ.

Environ Sci Technol. 2017 Jan 3;51(1):98-107. doi: 10.1021/acs.est.6b00566. Epub 2016 Dec 16.

30.

Frailty and Cause-Specific Hospitalization Among Persons Aging With HIV Infection and Injection Drug Use.

Piggott DA, Muzaale AD, Varadhan R, Mehta SH, Westergaard RP, Brown TT, Patel KV, Walston JD, Leng SX, Kirk GD.

J Gerontol A Biol Sci Med Sci. 2017 Mar 1;72(3):389-394. doi: 10.1093/gerona/glw142.

31.

Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.

Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V 3rd, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie EE, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, Napravnik S, Eron J, Gill MJ, Justice A, Peters MG, Goedert JJ, Mayor A, Thio CL, Cachay ER, Moore R; North American AIDS Cohort Collaboration on Research and Design of IeDEA; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.

Clin Infect Dis. 2016 Nov 1;63(9):1160-1167. Epub 2016 Aug 9.

32.

Provider-Level and Other Health Systems Factors Influencing Engagement in HIV Care: A Qualitative Study of a Vulnerable Population.

Lam Y, Westergaard R, Kirk G, Ahmadi A, Genz A, Keruly J, Hutton H, Surkan PJ.

PLoS One. 2016 Jul 18;11(7):e0158759. doi: 10.1371/journal.pone.0158759. eCollection 2016.

33.

Short Communication: HIV Controller T Cells Effectively Inhibit Viral Replication in Alveolar Macrophages.

Walker-Sperling VE, Merlo CA, Buckheit RW 3rd, Lambert A, Tarwater P, Kirk GD, Drummond MB, Blankson JN.

AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1097-1099. Epub 2016 Aug 2.

34.

A Shared Ethos: The Military Health System Strategic Partnership with the American College of Surgeons.

Knudson MM, Elster EE, Woodson J, Kirk G, Turner P, Hoyt DB.

J Am Coll Surg. 2016 Jun;222(6):1251-5. doi: 10.1016/j.jamcollsurg.2016.03.006. Epub 2016 Apr 22. No abstract available.

PMID:
27234634
35.

Implementation of a COPD Screening Questionnaire in an Outpatient HIV Clinic.

Lambert AA, Drummond MB, Kisalu A, Moxley J, Keruly J, Moore RD, Wise RA, Kirk GD.

COPD. 2016 Dec;13(6):767-772. Epub 2016 Apr 20.

36.

Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.

Kirkpatrick AR, Patel EU, Celum CL, Moore RD, Blankson JN, Mehta SH, Kirk GD, Margolick JB, Quinn TC, Eshleman SH, Laeyendecker O.

AIDS Res Hum Retroviruses. 2016 Aug;32(8):756-62. doi: 10.1089/AID.2015.0198. Epub 2016 May 5.

37.

Ecological Momentary Assessment of Illicit Drug Use Compared to Biological and Self-Reported Methods.

Linas BS, Genz A, Westergaard RP, Chang LW, Bollinger RC, Latkin C, Kirk GD.

JMIR Mhealth Uhealth. 2016 Mar 15;4(1):e27. doi: 10.2196/mhealth.4470.

38.

Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia.

An P, Penugonda S, Thorball CW, Bartha I, Goedert JJ, Donfield S, Buchbinder S, Binns-Roemer E, Kirk GD, Zhang W, Fellay J, Yu XF, Winkler CA.

PLoS Genet. 2016 Mar 4;12(3):e1005921. doi: 10.1371/journal.pgen.1005921. eCollection 2016 Mar.

39.

From Chaos to Competency: Implementing a New Competency Model in a Multihospital System.

Schanne LC, Stern S, Hand C, Collins M, Kirk G, Kweeder S, Brody R, LaPorta PH, Meehan D.

J Contin Educ Nurs. 2016 Mar;47(3):111-7; quiz 118-9. doi: 10.3928/00220124-20160218-06.

PMID:
26934075
40.

HIV Impairs Lung Epithelial Integrity and Enters the Epithelium to Promote Chronic Lung Inflammation.

Brune KA, Ferreira F, Mandke P, Chau E, Aggarwal NR, D'Alessio FR, Lambert AA, Kirk G, Blankson J, Drummond MB, Tsibris AM, Sidhaye VK.

PLoS One. 2016 Mar 1;11(3):e0149679. doi: 10.1371/journal.pone.0149679. eCollection 2016.

41.

Rice Genotype Differences in Tolerance of Zinc-Deficient Soils: Evidence for the Importance of Root-Induced Changes in the Rhizosphere.

Mori A, Kirk GJ, Lee JS, Morete MJ, Nanda AK, Johnson-Beebout SE, Wissuwa M.

Front Plant Sci. 2016 Jan 11;6:1160. doi: 10.3389/fpls.2015.01160. eCollection 2015.

42.

Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection.

Patel EU, Cox AL, Mehta SH, Boon D, Mullis CE, Astemborski J, Osburn WO, Quinn J, Redd AD, Kirk GD, Thomas DL, Quinn TC, Laeyendecker O.

J Infect Dis. 2016 Aug 1;214(3):344-52. doi: 10.1093/infdis/jiw005. Epub 2016 Jan 14.

43.

Prevalence of and Risk Factors for Oral Human Papillomavirus Infection among HIV-Positive and HIV-Negative People Who Inject Drugs.

Robbins HA, Fennell CE, Gillison M, Xiao W, Guo Y, Wentz A, Kirk GD, Mehta SH, D'Souza G.

PLoS One. 2015 Nov 24;10(11):e0143698. doi: 10.1371/journal.pone.0143698. eCollection 2015.

44.

Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.

McLaren PJ, Coulonges C, Bartha I, Lenz TL, Deutsch AJ, Bashirova A, Buchbinder S, Carrington MN, Cossarizza A, Dalmau J, De Luca A, Goedert JJ, Gurdasani D, Haas DW, Herbeck JT, Johnson EO, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, Poli G, Sandhu MS, Schuitemaker H, Shea PR, Theodorou I, Walker BD, Weintrob AC, Winkler CA, Wolinsky SM, Raychaudhuri S, Goldstein DB, Telenti A, de Bakker PI, Zagury JF, Fellay J.

Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14658-63. doi: 10.1073/pnas.1514867112. Epub 2015 Nov 9.

45.

Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.

Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D'Souza G, Engels EA, Hessol NA, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, Kitahata MM, Korthuis PT, Mathews WC, Mayor A, Modur SP, Napravnik S, Novak RM, Patel P, Rachlis AR, Sterling TR, Willig JH, Justice AC, Moore RD, Dubrow R; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.

Ann Intern Med. 2015 Oct 6;163(7):507-18. doi: 10.7326/M14-2768.

46.

Associations of Circulating Soluble Tumor Necrosis Factor-α Receptors 1 and 2 with Interleukin-6 Levels in an Aging Cohort of Injection Drug Users with or at High Risk for HIV Infection.

Leng SX, Dandorf S, Li H, Carlson J, Hui J, Mehta SH, Piggott D, Islam S, Manwani B, Kirk GD.

AIDS Res Hum Retroviruses. 2015 Dec;31(12):1257-64. doi: 10.1089/AID.2015.0134. Epub 2015 Oct 13.

47.

Frailty, Inflammation, and Mortality Among Persons Aging With HIV Infection and Injection Drug Use.

Piggott DA, Varadhan R, Mehta SH, Brown TT, Li H, Walston JD, Leng SX, Kirk GD.

J Gerontol A Biol Sci Med Sci. 2015 Dec;70(12):1542-7. doi: 10.1093/gerona/glv107. Epub 2015 Sep 18.

48.

Factors associated with abnormal spirometry among HIV-infected individuals.

Drummond MB, Huang L, Diaz PT, Kirk GD, Kleerup EC, Morris A, Rom W, Weiden MD, Zhao E, Thompson B, Crothers K.

AIDS. 2015 Aug 24;29(13):1691-700. doi: 10.1097/QAD.0000000000000750.

49.

Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.

O'Brien TR, Pfeiffer RM, Paquin A, Lang Kuhs KA, Chen S, Bonkovsky HL, Edlin BR, Howell CD, Kirk GD, Kuniholm MH, Morgan TR, Strickler HD, Thomas DL, Prokunina-Olsson L.

J Hepatol. 2015 Nov;63(5):1103-10. doi: 10.1016/j.jhep.2015.06.035. Epub 2015 Jul 15.

50.

Uptake and Acceptability of Information and Communication Technology in a Community-Based Cohort of People Who Inject Drugs: Implications for Mobile Health Interventions.

Genz A, Kirk G, Piggott D, Mehta SH, Linas BS, Westergaard RP.

JMIR Mhealth Uhealth. 2015 Jun 25;3(2):e70. doi: 10.2196/mhealth.3437.

Supplemental Content

Support Center